USP29 stabilizes oncogenic MYC (including c-MYC and N-MYC) and hypoxia-induced factor 1α (HIF1α), which are two major drivers of cancer metabolism in normoxia and hypoxia, respectively, by direct interaction and deubiquitination. Here, MYCN is linked to cancer.